471 results on '"Verde, Federico"'
Search Results
2. How to detect affect recognition alterations in amyotrophic lateral sclerosis
3. Ecological validity of performance-based cognitive screeners in amyotrophic lateral sclerosis: preliminary evidence
4. Clinical usefulness of the Verbal Fluency Index (VFI) in amyotrophic lateral sclerosis
5. Prevalence and motor-functional correlates of frontotemporal-spectrum disorders in a large cohort of non-demented ALS patients
6. Verbal learning in frontal patients: area 9 is critical for employing semantic strategies
7. Shaping the Neurovascular Unit Exploiting Human Brain Organoids
8. Clinical and neuroanatomical characterization of the semantic behavioral variant of frontotemporal dementia in a multicenter Italian cohort
9. Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
10. Further insights into anti-IgLON5 disease: a case with complex clinical presentation
11. Duropathy as a rare motor neuron disease mimic: from bibrachial amyotrophy to infratentorial superficial siderosis
12. Correction to: Verbal learning in frontal patients: area 9 is critical for employing semantic strategies
13. Advancing Italian Biomedical Information Extraction with Transformers-based Models: Methodological Insights and Multicenter Practical Application
14. Validity, diagnostics and feasibility of the Italian version of the Montreal Cognitive Assessment (MoCA) in Huntington’s disease
15. The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis
16. Correction: Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients
17. Quantification of serum TDP-43 and neurofilament light chain in patients with amyotrophic lateral sclerosis stratified by UNC13A genotype
18. Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
19. Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
20. Phosphorylated tau in plasma could be a biomarker of lower motor neuron impairment in amyotrophic lateral sclerosis
21. Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients
22. Influence of kidney function and CSF/serum albumin ratio on plasma Aβ42 and Aβ40 levels measured on a fully automated platform in patients with Alzheimer’s disease
23. Clinical usability of the Story-Based Empathy Task (SET) in non-demented ALS patients
24. Equating norms between the ALS Cognitive Behavioral Screen (ALS-CBS™) and the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) in non-demented ALS patients
25. Lower semantic fluency scores and a phonemic-over-semantic advantage predict abnormal CSF P-tau181 levels in Aβ + patients within the Alzheimer’s disease clinical spectrum
26. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson’s disease patients
27. Relationship between cerebrospinal fluid/serum albumin quotient and phenotype in amyotrophic lateral sclerosis: a retrospective study on 328 patients
28. Clinimetrics of the cognitive section of the Italian ALS Cognitive Behavioral Screen (ALS-CBS™)
29. Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience
30. Genomic and transcriptomic advances in amyotrophic lateral sclerosis
31. Diagnostic properties of the Italian ECAS Carer Interview (ECAS-CI)
32. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer’s disease compared to neurological disease controls: a retrospective study on 276 patients
33. Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
34. Feasibility and diagnostics of the Frontal Assessment Battery (FAB) in amyotrophic lateral sclerosis
35. Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
36. Progressive motor neuron syndromes with single CNS lesions and CSF oligoclonal bands: never forget solitary sclerosis!
37. A + T ± status across MCI and dementia due to AD: a clinic-based, retrospective study
38. Serum neurofilament light chain levels in Covid-19 patients without major neurological manifestations
39. Amyotrophic Lateral Sclerosis: Neurochemical Biomarkers
40. Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis
41. Correction to: Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
42. QSM-detected iron accumulation in the cerebellar gray matter is selectively associated with executive dysfunction in non-demented ALS patients.
43. Tau proteins in blood as biomarkers of Alzheimer’s disease and other proteinopathies
44. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.
45. Unleashing the potential of mRNA therapeutics for inherited neurological diseases
46. Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients
47. Clinical and Neuroanatomical Characterization of the Semantic Behavioural Variant of Frontotemporal Dementia in a Multicentre Italian Cohort (P4-9.004)
48. Breaking Diagnostic Barriers: NODDI-Machine learning Fusion for FTD Differential Diagnosis (S1.007)
49. Next-generation sequencing application to investigate skeletal muscle channelopathies in a large cohort of Italian patients
50. Medical Information Extraction With NLP-Powered QABots: A Real-World Scenario
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.